Clinical performance of endobronchial ultrasound-guided transbronchial needle aspiration for assessing programmed death ligand-1 expression in nonsmall cell lung cancer

Diagnostic Cytopathology
Abhishek BiswasHiren J Mehta

Abstract

Pembrolizumab was recently approved as a first line agent for metastatic NSCLC in patients with high programmed death-ligand 1 (PD-L1) expression. Since a significant portion of lung cancer is diagnosed by endobronchial ultrasound-guided transbronchial needle aspiration (EBUS TBNA); there is a need for PD-L1 testing in these specimens. However, to date few studies have evaluated performance of cytology specimens from EBUS TBNA for PD-L1 analysis. Patients who had a diagnosis of NSCLC and in whom ancillary testing, i.e., next generation sequencing (NGS), anaplastic lymphoma kinase (ALK), and PD-L1 expression was requested between January and May 2017 were reviewed. Fifty of the 112 patients reviewed had the diagnosis of NSCLC for which ancillary testing was requested. Twelve patients (24%) had squamous cell carcinoma, twenty-seven had adenocarcinoma (54%), five had NSCLC favor adenocarcinoma (10%), two had NSCLC favor squamous cell cancer (4%), and four had NSCLC not otherwise specified (NOS) (8%). Size of the lymph nodes or lesion sampled ranged from 10 to 50 mm. Four (8%) patients had insufficient number of tumor cells in the cell block for any of the ancillary molecular testing. Forty-one (82%) patients had an adequate sample...Continue Reading

References

Jan 25, 2011·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Rita NizzoliAndrea Ardizzoni
Mar 8, 2011·Cell·Douglas Hanahan, Robert A Weinberg
Jul 20, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Andrew H FischerNancy A Young
Nov 13, 2013·Laboratory Investigation; a Journal of Technical Methods and Pathology·Vamsidhar VelchetiDavid L Rimm
Apr 22, 2015·The New England Journal of Medicine·Edward B GaronUNKNOWN KEYNOTE-001 Investigators
Jan 9, 2016·CA: a Cancer Journal for Clinicians·Rebecca L SiegelAhmedin Jemal
Oct 25, 2016·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Tzahi NeumanGilad W Vainer
Oct 11, 2016·The New England Journal of Medicine·Martin ReckUNKNOWN KEYNOTE-024 Investigators
Dec 28, 2016·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Irina DemidovaSergey Tjulandin
Jan 24, 2017·Clinical Lung Cancer·Rie SakakibaraYuichi Ishikawa
Feb 22, 2017·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Sehui KimDoo Hyun Chung

❮ Previous
Next ❯

Citations

Jun 26, 2018·Cytopathology : Official Journal of the British Society for Clinical Cytology·Deepali JainVenkateswaran K Iyer
Aug 29, 2018·Cytopathology : Official Journal of the British Society for Clinical Cytology·Aruna Nambirajan, Deepali Jain
May 3, 2019·Cancer Cytopathology·Deepali JainUNKNOWN IASLC Pathology Committee
May 21, 2019·Journal of Bronchology & Interventional Pulmonology·Sebastian Fernandez-BussyHiren J Mehta
Jul 20, 2019·Expert Review of Respiratory Medicine·Yuichi SakairiIchiro Yoshino
Oct 5, 2019·Applied Immunohistochemistry & Molecular Morphology : AIMM·Carol C CheungUNKNOWN Canadian Association of Pathologists-Association Canadienne Des Pathologistes’ National Standards Committee for High Complex
Aug 12, 2020·Japanese Journal of Clinical Oncology·Keigo UchimuraKazuhiro Yatera
Oct 28, 2018·International Journal of Molecular Sciences·Oscar B Knights, James R McLaughlan
Oct 23, 2020·Diagnostic Cytopathology·Andrea Ambrosini-SpaltroVenerino Poletti
Feb 3, 2020·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·John R GosneyKeith M Kerr

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.